Annual CFI
$13.87 M
+$702.00 K+5.33%
31 December 2023
Summary:
Applied Therapeutics annual cash flow from investing activities is currently $13.87 million, with the most recent change of +$702.00 thousand (+5.33%) on 31 December 2023. During the last 3 years, it has risen by +$33.34 million (+171.25%). APLT annual CFI is now at all-time high.APLT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Applied Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.APLT quarterly CFI is now -100.00% below its all-time high of $28.44 million, reached on 31 December 2020.APLT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Applied Therapeutics TTM cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$6.97 million (-100.00%). APLT TTM CFI is now -100.00% below its all-time high of $46.63 million, reached on 31 March 2022.APLT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.3% | 0.0% | -100.0% |
| 3 y3 years | +171.3% | -100.0% | -100.0% |
| 5 y5 years | +100.0% | +100.0% | +100.0% |
APLT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +171.3% | -100.0% | +100.0% | -100.0% | |
| 5 y | 5 years | at high | +169.3% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | at high | +169.3% | -100.0% | +100.0% | -100.0% | +100.0% |
Applied Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2023 | $13.87 M(+5.3%) | $0.00(0.0%) | $13.87 M(+99.1%) |
| Sept 2023 | - | $0.00(0.0%) | $6.97 M(-41.9%) |
| June 2023 | - | $0.00(-100.0%) | $11.99 M(-31.6%) |
| Mar 2023 | - | $13.87 M(-300.9%) | $17.52 M(+33.0%) |
| Dec 2022 | $13.17 M(+5.9%) | -$6.91 M(-237.5%) | $13.17 M(-58.7%) |
| Sept 2022 | - | $5.02 M(-9.2%) | $31.88 M(-9.9%) |
| June 2022 | - | $5.53 M(-42.0%) | $35.38 M(-24.1%) |
| Mar 2022 | - | $9.53 M(-19.3%) | $46.63 M(+275.1%) |
| Dec 2021 | $12.43 M | $11.81 M(+38.6%) | $12.43 M(-57.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $8.52 M(-49.2%) | $29.07 M(-399.9%) |
| June 2021 | - | $16.78 M(-168.0%) | -$9.69 M(+298.9%) |
| Mar 2021 | - | -$24.67 M(-186.7%) | -$2.43 M(-87.5%) |
| Dec 2020 | -$19.47 M(-2.7%) | $28.44 M(-194.0%) | -$19.47 M(-59.5%) |
| Sept 2020 | - | -$30.25 M(-225.8%) | -$48.04 M(+27.5%) |
| June 2020 | - | $24.04 M(-157.6%) | -$37.67 M(-39.0%) |
| Mar 2020 | - | -$41.71 M(>+9900.0%) | -$61.72 M(+208.5%) |
| Dec 2019 | -$20.01 M(<-9900.0%) | -$128.00 K(-99.4%) | -$20.01 M(+0.6%) |
| Sept 2019 | - | -$19.88 M(<-9900.0%) | -$19.88 M(<-9900.0%) |
| June 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00 | $0.00 |
FAQ
- What is Applied Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Applied Therapeutics?
- What is Applied Therapeutics annual CFI year-on-year change?
- What is Applied Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Applied Therapeutics?
- What is Applied Therapeutics quarterly CFI year-on-year change?
- What is Applied Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Applied Therapeutics?
- What is Applied Therapeutics TTM CFI year-on-year change?
What is Applied Therapeutics annual cash flow from investing activities?
The current annual CFI of APLT is $13.87 M
What is the all time high annual CFI for Applied Therapeutics?
Applied Therapeutics all-time high annual cash flow from investing activities is $13.87 M
What is Applied Therapeutics annual CFI year-on-year change?
Over the past year, APLT annual cash flow from investing activities has changed by +$702.00 K (+5.33%)
What is Applied Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of APLT is $0.00
What is the all time high quarterly CFI for Applied Therapeutics?
Applied Therapeutics all-time high quarterly cash flow from investing activities is $28.44 M
What is Applied Therapeutics quarterly CFI year-on-year change?
Over the past year, APLT quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Applied Therapeutics TTM cash flow from investing activities?
The current TTM CFI of APLT is $0.00
What is the all time high TTM CFI for Applied Therapeutics?
Applied Therapeutics all-time high TTM cash flow from investing activities is $46.63 M
What is Applied Therapeutics TTM CFI year-on-year change?
Over the past year, APLT TTM cash flow from investing activities has changed by -$6.97 M (-100.00%)